Judith K. Wolf

Oncology
200 High Park Ave
Goshen, IN 46526

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Editor's Note: Therapeutic Targeting of ATP7B in Ovarian Carcinoma.

Editor's Note: Therapeutic Targeting of ATP7B in Ovarian Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 03, 2021

Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer.

Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 16, 2020

Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer.

Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 12, 2020

A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women over age 50 with BI-RADS 3, 4, or 5 Assessment.

A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women over age 50 with BI-RADS 3, 4, or 5 Assessment.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 22, 2018

A Combinatorial Proteomic Biomarker Assay to Detect Ovarian Cancer in Women.

A Combinatorial Proteomic Biomarker Assay to Detect Ovarian Cancer in Women.

Journal: Biomarkers in cancer
Published: October 11, 2017

Breast density does not impact the ability of Videssa® Breast to detect breast cancer in women under age 50.

Breast density does not impact the ability of Videssa® Breast to detect breast cancer in women under age 50.

Journal: PloS one
Published: May 26, 2017

The clinical utility of an elevated-risk multivariate index assay score in ovarian cancer patients.

The clinical utility of an elevated-risk multivariate index assay score in ovarian cancer patients.

Journal: Current medical research and opinion
Published: April 08, 2016

Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses.

Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses.

Journal: American journal of obstetrics and gynecology
Published: November 10, 2015

Ovarian serous carcinoma associated with a distinct "corded and hyalinized" pattern.

Ovarian serous carcinoma associated with a distinct "corded and hyalinized" pattern.

Journal: Archives of pathology & laboratory medicine
Published: February 02, 2013

Evaluation of pegylated liposomal doxorubicin dose on the adverse drug event profile and outcomes in treatment of recurrent endometrial cancer.

Evaluation of pegylated liposomal doxorubicin dose on the adverse drug event profile and outcomes in treatment of recurrent endometrial cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: January 09, 2013

Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer.

Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer.

Journal: Gynecologic oncology
Published: January 20, 2012
Showing 1-11 of 11

Last Updated: 09/26/2026